Compare AIRS & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIRS | BLND |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.7M | 364.2M |
| IPO Year | 2021 | 2021 |
| Metric | AIRS | BLND |
|---|---|---|
| Price | $2.42 | $1.41 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 929.4K | ★ 1.9M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.33 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $151,818,000.00 | $123,585,000.00 |
| Revenue This Year | $5.19 | $12.62 |
| Revenue Next Year | $5.32 | $14.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.51 | $1.18 |
| 52 Week High | $12.00 | $4.49 |
| Indicator | AIRS | BLND |
|---|---|---|
| Relative Strength Index (RSI) | 34.07 | 40.98 |
| Support Level | $1.85 | $1.35 |
| Resistance Level | $3.36 | $1.60 |
| Average True Range (ATR) | 0.19 | 0.07 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 1.64 | 20.00 |
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segment is Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience. The key revenue for the company is generated from the Blend Platform segment. Company has it's assets in united states, India and Mexico regions.